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The aim of present study was to investigate the possible protective effects of an ethanolic stem bark extract of 
Terminalia ivorensis on gentamicin – induced nephrotoxicity and hepatotoxicity in male Sprague-Dawley rats.  
Groups of animals received either gentamicin alone or in combination with 100, 300 or 1000 mg/kg of extract for 
a period of 14 days. On the 15
th
 day, the modulatory effect of Terminalia ivorensis was examined by assessing 
biochemical and renal markers of hepatic and renal damage. Markers of oxidative injury including reduced 
glutathione, superoxide dismutase, catalase and lipid peroxidation were assessed. Histology of the kidneys and 
the liver were also processed for analysis. The extract at a dose of 100-1000 mg/kg significantly reduced 
elevations in creatinine, urea and serum enzymes evokedby gentamicin.  Additionally, the low levels of reduced 
glutathione and the antioxidant enzymes from the gentamicin treatment were significantly improved in the 
extract-treated animals. The results correlated well with the histopathological findings as the extract reversed the 
severe architectural distortions of the kidneys and liver caused by gentamicin. We conclude from the study that, 
the ethanolic stem bark extract of Terminalia ivorensis protects the liver and the kidneys against gentamicin-
induced renal and hepatic damage. 
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Nephrotoxicity is a common and serious side effect of 
conventional medications (Rajitha et al., 2013). Available records 
indicate that 27 million people have chronic kidney disease with a 
rise of 30% over the past decade (Coresh et al., 2007). Renal 
insufficiency is observed in nearly 2% cases of acetaminophen 
over dosage and the occurrence of renal dysfunction from 
aminoglycosides especially gentamicin increased from 3% in 
1969 to 10-20% in the past few years (Eslami et al., 2011; Rajitha 
et al., 2013). Renal injury is also caused by various compounds 
including potassium dichromate (Pedraza-Chaverri, 2008) used in 
the metallurgical, chrome plating, paint, leather tanning, 
photographic, textile manufacturing and wood preservation 
industries. The nephrotoxic effect of the aminoglycosides has 
been strongly linked to the preferential accumulation in renal 
cortex (Luft and Kleit, 1974). Another common and relevant 
adverse effect of drug therapy is hepatotoxicity, which accounts         
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for 5% of all  hospitalized cases and 75% of adverse reactions 
resulting in death (Sivakrishnan and Kottaimuthu, 2013; Aashish et 
al., 2012). Consequently, hepatic injury has been a common cause 
of drug withdrawal from the market (Jaeschke et al., 2002). The 
integrity of the kidney and the liver are compromised in injury. 
This could exacerbate the conditions since these are the main 
organs for drug metabolism and consequent elimination from the 
body. Available drugs for the management of renal and hepatic 
injury are rather limited. Medicinal plants have been used for the 
cure of several human diseases and are gaining more acceptability 
due to less toxicity and high efficacy (Aslam et al., 2013). Among 
the medicinal plants used for the treatment of various diseases is 
Terminalia ivorensis. Terminalia ivorensis A. Chev 
(Combretaceae) is a tree located in the tropical and sub-tropical 
regions of the world (Burkill, 1985). The plant has several 
traditional uses. For example, it has been used to treat ulcers, cuts, 
sores, wounds, general body pains, hemorrhoids, malaria, yellow 
fever and for the induction of diuresis (Quattara et al., 2013; 
Akinyemi et al., 2006; Etukudo, 2003; Burkill, 1985). Gentamicin 
is used widely in the treatment of gram-negative infections. 
Gentamicin is known to be potentially nephrotoxic at levels 
marginally above the therapeutic dose (Pedraza et al., 2000; 
Conlon et al., 1999).  
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Renal damage induced by the aminoglycosides can be 
accompanied by liver injury (Martines et al., 1988). Considering 
the effectiveness of gentamicin in the management of gram-
negative infections albeit the potential to evoke renal and hepatic 
damage, a plant drug administered concomitantly to modulate the 
risk of nephrotoxicity and hepatotoxicity would be worthwhile. 
We evaluated Terminalia ivorensis in the present study against 
gentamicin-induced nephrotoxicity and hepatotoxicity on the basis 
of its traditional use on the urinary system and the reported wide 
traditional uses of the plant. 
 
MATERIALS AND METHODS 
 
Preparation of plant material 
Stem bark of Terminalia ivorensis was collected from 
Asakraka Kwahu in the Eastern region (Ghana)in September 2014 
and authenticated at the Department of Pharmacognosy, Faculty of 
Pharmacy and Pharmaceutical Sciences KNUST Kumasi Ghana 
by Dr.  Kofi Annan.  A voucher herbarium specimen number 
FP/095/10 was prepared and deposited in the department’s 
herbarium. The harvested stem bark was washed, air dried for 14 
days and ground with a laboratory blender. It was weighed and 
extracted with 70 % ethanol. The sample was oven dried at 
55ᴼCand the yield obtained was 24.3 % w/w, referred in this paper 
as TIE. TIE was stored in a refrigerator until use. The extract was 
freshly dissolved in distilled water, which was used as vehicle for 
the control group. Administration to the animals was oral by 
gavage and the concentrations were prepared such that no animal 
received more than 1.0 mL/kg body weight. 
 
Animals 
Male Sprague – Dawley rats (180 – 240g) were obtained 
from the Animal house of the Department of Pharmacology, 
Kwame Nkrumah University of Science and Technology 
(KNUST), Kumasi, Ghana. The animals were acclimatized for one 
week with free access to laboratory feed and water ad libitum. All 
the animals were housed in aluminium laboratory cages (34 x 47 x 
18 cm) with fine wood shavings as bedding. Animals were 
humanely treated and all experiments were approved by the 
Faculty of Pharmacy and Pharmaceutical Sciences ethics 
committee. 
 
Effect of extract on gentamicin– induced nephrotoxicity and 
hepatotoxicity 
The method used was as described by Qadir et al., 
(2011). Briefly, thirty (30) male Sprague – Dawley rats (180 – 240 
g) were weighed, put into five groups (n =6) and left to acclimatize 
to their new environment for one week with adequate fresh water 
and feed. Animals were grouped and drugs administered as 
follows: 
 Group I (control): received distilled water (1 
mL/kg/day p.o) for 14 days. 
 Group II received gentamicin (80 mg/kg/day i.p.) for 
14 days. 
 Group III: received extract (100 mg/kg/dayp.o) + 
gentamicin (80mg/kg/day i.p.) for 14 days. 
 Group IV: received extract (300 mg/kg/day p.o) + 
gentamicin (80mg/kg/day i.p.) for 14 days. 
 Group V: received extract (1000 mg/kg/day p.o) + 
gentamicin (80mg/kg/day i.p.) for 14 days. 
 
Treatment of animals with the extract for groups III, IV and V 
started 3 days prior to the commencement of the study. Injection of 
gentamicin was done at 10:00 hours to minimize the circadian 
variation in nephrotoxicity. On day 14, all animals were put in 
metabolic cages for collection of 24 – hour urine sample. On the 
15
th
 day, all animals were weighed and blood samples collected for 
estimation of serum electrolytes, blood urea and creatinine levels 
as well as liver biomarkers. All animals were then sacrificed and 
their kidneys and livers removed, washed with normal saline and 
weighed. The right kidneys and livers were preserved for 
histopathological studies while left kidneys were used for 
preparation of post – mitochondrial supernatant. 
 
Estimation of renal and liver biomarkers 
Blood samples were centrifuged at 5000 r.p.m for 10 
minutes to obtain sera which were used for the estimation of the 
kidney and liver biochemical markers. Urea and creatinine were 
determined with Biotecnica BT 3000 Targa chemistry analyzer 
(Diamond Diagnostics, USA). Measurement of sodium, potassium 
and chloride were done with Flexor Junior Auto analyzer. Liver 
biomarkers were also measured with Biotecnica BT 3000 Targa 
chemistry analyzer (Diamond Diagnostics, USA).  
 
Preparation of tissue homogenate 
Left kidneys were quickly removed, cleaned and 
immediately stored in ice-cold saline (0.85 % sodium chloride). 
Kidneys were homogenized in phosphate buffer (0.1M, pH 7.4) 
containing KCl (1.17%) at 4 ᴼC with Potter-Elvehjem 
homogenizer (Ultra-Turrax T25, Janke & Kunkel IKA- 
Labortechnik, Germany). The homogenate was filtered with a 
clean handkerchief and centrifuged with Hettich-zentrifugen 
(Micro 220R, Germany) at 800 X g for 5 minutes at 4 ᴼC. The 
supernatant was again centrifuged at 5000 r.p.m for 30 minutes at 
4 ᴼC to obtain the tissue homogenate which was used as the 
enzyme source for the biochemical estimations. All the 
experiments were performed within 24 hours of animal sacrifice - 
 
Estimation of markers of oxidative stress 
The method of Ellman, (1959) was used for estimation of 
reduced glutathione.  Superoxide dismutase levels were measured 
as described by Sun et al., (1988) and catalase activity was 
assessed using a method of Sinha, (1972). Lipid peroxidation was 
examined in terms of malondialdehyde (MDA) formed as 
described by Ohkawa et al., (1979) and the amount of 
myeloperoxidase (MPO) formed was evaluated using the method 
of Senoglu et al., (2009).  



































Immediately after sacrifice, right kidneys of rats were 
stored in neutral buffered formalin (10 %) for histological 
processing. Sections of the kidneys and livers were stained with 
hemotoxylin and eosin, and observed under a Leica DM 750 
microscope (ICC50 HD, JosHansen, Germany) at magnifications 
of X 400 for kidneys and X100 for livers. 
 
Data analysis 
Data analysis was done with GraphPad Prism 6.0. All 
results were presented as mean ± standard error of mean (SEM) 
and (p< 0.05) was considered significant. Comparison within 
groups was done using One Way Analysis of Variance (ANOVA) 




Effect of gentamicin and TIE on renal parameters and 
electrolytes 
Serum creatinine levels were significantly elevated in the 
gentamicin-only treated group (p< 0.001) compared to the control, 

































in extract pre-treated groups when compared to the               
gentamicin group. Similarly, gentamicin significantly (p< 0.001) 
increased the serum urea levels of rats when compared to the 
control. However, reduced serum urea levels were observed in 
animals pretreated with 300 (p< 0.001) and 1000 mg/kg of extract 
(p< 0.01) when compared to the gentamicin treated group (Table 
1). Serum electrolytes (sodium, potassium and chloride) were 
significantly (p< 0.001) increased in the gentamicin-only treated 
group. The group treated with 300 mg/kg TIE and gentamicin (80 
mg) caused significant reduction in sodium (p<0.01), potassium 
(p< 0.001) and chloride levels (p< 0.001). Similarly, combination 
treatment of 1000 mg/kg TIE and gentamicin reduced the 
electrolytes significantly (p<0.001) to normal levels.  
TIE 100 mg/kg with gentamicin decreased potassium 
(p<0.001) and chloride (p<0.01 but not sodium levels (Table 2).  
 
Effect of TIE and Gentamicin on antioxidant enzymes 
Gentamicin (80 mg/kg), significantly (p< 0.001) 
decreased tissue GSH of rats compared to the control. Pretreatment 
with 300 and 1000 mg/kg TIE significantly (p< 0.01; p< 0.001 
respectively) restored the GSH levels compared to the gentamicin-
only treated group (Figure 1). The oxidative stress caused by the 
Table 1: Effect of TIE and Gentamicin on serum creatinine and urea. 
Treatment group Creatinine/ μmol/L Urea/ mmol/L 
Control: distilled 10 ml/kg 33.10 ± 1.77 11.66 ± 0.67 
Gent 80 mg/kg 102.70±11.75*** 22.42 ± 2.90*** 
TIE 100 mg/kg + Gent 80 mg/kg 59.03±2.78*ᵗᵗᵗ 16.36 ±0.99 
TIE 300 mg/kg + Gent 80 mg/kg 47.83±3.51ᵗᵗᵗ 12.86 ± 0.66ᵗᵗᵗ 
TIE 1000 mg/kg + Gent 80 mg/kg 53.48±5.74ᵗᵗᵗ 13.21 ± 0.82ᵗᵗ 
All data are expressed as mean ± S.E.M. (n=6), *p< 0.05, **p< 0.01 and ***p< 0.001 as compared to the control group (one way ANOVA followed by Sidak’s 
post hoc test). ᵗᵗp< 0.01 and ᵗᵗᵗp< 0.001 as compared to gentamicin group (one way ANOVA followed by Sidak’s post hoc test).  
 
Table 2: Effect of TIE and Gentamicin on serum sodium, potassium and chloride levels. 
Treatment group Sodium/ m/L Potassium/ m/L Chloride/ m/L 
Control: distilled 10 ml/kg 115.3 ± 2.45 8.48 ± 0.46 78.33 ± 1.61 
Gent 80 mg/kg 135.2 ± 2.80*** 16.40 ± 0.50*** 98.67 ± 1.71*** 
TIE 100 mg/kg + Gent 80 mg/kg 136.7±1.43*** 13.10 ± 0.49***ᵗᵗᵗ 90.67± 0.88***ᵗᵗ 
TIE 300 mg/kg + Gent 80 mg/kg 123.2 ±0.60ᵗᵗ 11.00 ± 0.33**ᵗᵗᵗ 84.83 ± 0.95*ᵗᵗᵗ 
TIE 1000 mg/kg + Gent 80 mg/kg 118.0 ± 1.77ᵗᵗᵗ 9.53 ± 0.28ᵗᵗᵗ 80.67 ± 0.76ᵗᵗᵗ 
All data are expressed as mean ± S.E.M. (n=6), *p< 0.05, **p< 0.01 and ***p< 0.001 when compared to the control group (one way ANOVA followed by Sidak’s 
post hoc test). ᵗᵗp< 0.01 and ᵗᵗᵗp< 0.001 when compared to gentamicin group (one way ANOVA followed by Sidak’s post hoc test).  
 
 
Fig. 1: Effect of gentamicin (80 mg/kg) and TIE (100, 300, 1000 mg/kg) on 
GSH levels. **p< 0.01 and ***p< 0.001 as compared to the control group 
(one way ANOVA followed by Sidak’s post hoc test). ᵗᵗp< 0.01 and ᵗᵗᵗp< 
0.001 when compared to gentamicin group (one way ANOVA followed by 
Sidak’s post hoc test).  
 
Fig. 2: Effect of gentamicin (80 mg/kg) and TIE (100, 300, 1000 mg/kg) on 
SOD levels. *p< 0.05 and ***p< 0.001 as compared to the control group (one 
way ANOVA followed by Sidak’s post hoc test). ᵗᵗp< 0.01 and ᵗᵗᵗp< 0.001 when 
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gentamicin treatment significantly (p< 0.001) decreased kidney 
superoxide dismutase levels in treated animals compared to the 
control group. However, SOD increased significantly (p< 0.01; 
p<0.001 and p<0.001) in animals that received 100 mg/kg, 300 
and 1000 mg/kg of extract respectively in combination with 
gentamicin (Figure 2). Gentamicin (80 mg/kg) reduced catalase 
significantly (p< 0.001) compared to the control group. Animals 
that received gentamicin with extract at 300 and 1000 mg/kg 
significantly (p< 0.001) improved catalase levels compared to the 
gentamicin-only group (Figure 3).  
 
 
Fig. 3: Effect of gentamicin (80 mg/kg) and TIE (100, 300, 1000 mg/kg) on 
catalase levels. ***p< 0.001 as compared to the control group (one way  
NOVA followed by Sidak’s post hoc test) and ᵗᵗᵗp< 0.001 when compared to 
gentamicin group (one way ANOVA followed by Sidak’s post hoc test).  
 
Effect of TIE and Gentamicin on lipid peroxidation 
Lipid peroxidation was measured in terms of the amount 
of malondialdehyde (MDA) produced. Induction of oxidative 
stress with gentamicin significantly increased the amount of MDA 
produced in the gentamicin-only treated group (p< 0.001) when 
compared to the control group. MDA formation was however 
significantly obliterated in animals treated with gentamicin and the 
extract at 100 (p< 0.05), 300 (p< 0.01) and 1000 mg/kg (p< 0.001) 
compared to the gentamicin-only group (Figure 4).  
 
 
Fig. 4:Effect of Gentamicin (80 mg/kg) and TIE (100, 300, 1000                     
mg/kg) on MDA levels. *p< 0.05 and ***p< 0.001 as compared to                      
the control group (one way ANOVA followed by Sidak’s post                            
hoc test). ᵗp< 0.05, ᵗᵗp< 0.01 and ᵗᵗᵗp< 0.001 when compared to gentamicin 
group (one way ANOVA followed by Sidak’s post hoc test).  
 
Effect of TIE and Gentamicin on myeloperoxidase (MPO) 
levels 
A significant increase (p< 0.001) in tissue MPO levels 
was found in gentamicin-only treated groups compared to the 
control group. Rats treated with extract (300 and 1000 mg/kg) 
significantly (p< 0.01) showed decreased MPO formation when 
compared to the gentamicin-only group (Figure 5).  
 
 
Fig. 5: Effect of gentamicin (80 mg/kg) and TIE (100, 300, 1000 mg/kg) on 
MPO levels. ***p< 0.001 as compared to the control group (one way ANOVA 
followed by Sidak’s post hoc test) and ᵗᵗᵗp< 0.001 when compared to 
gentamicin group (one way ANOVA followed by Sidak’s post hoc test).  
 
Photomicrographs of kidneys showing the effect of TIE on 
gentamicin–induced nephrotoxicity 
Assessment of histomorphology of the kidneys showed 
normal glomerular and tubular histology in the medulla and 
cortical regions in control group. Gentamicin evoked severe 
glomerular degeneration, vacuolization, tubular casts and necrosis. 
In contrast, rats that received the extract at 100 mg/kgwith 
gentamicin showed a moderate reversal of renal injury. 
Combination treatment of gentamicin and extract at 300 and 1000 
mg/kg improved the renal injury dose-dependently compared to 
the control group (Figure 6) 
 
Effect of TIE and Gentamicin on AST, ALT and GGT 
The effect of the extract on gentamicin-induced liver 
damage was also assessed. Expectedly, significant elevation in 
AST (p< 0.05), ALT (p< 0.01) and GGT (p< 0.01) were observed 
in the gentamicin-only treated group compared to the control. The 
extract at 1000 mg/kg however, significantly (p<0.05) reversed the 
AST, ALT and the GGT levels compared to the gentamicin group.  
The extract at 300 mg/kg reduced only the ALT significantly 
(p<0.05) but not AST or ALT (Table 3).  
 
Effect of TIE and Gentamicin on ALP, total bilirubin, and 
total protein levels 
Induction of liver damage with gentamicin, significantly 
(p< 0.01) increased ALP when compared to the control. The 
extract at 1000 mg/kg significantly (p< 0.05) reduced ALP when 
compared to the gentamicin group. Total bilirubin increased 
significantly (p< 0.01) in the gentamicin-only treated group 
compared to the control.  










































The extract however, significantly reduced total bilirubin 
dose-dependently at 300 (p< 0.05) and 1000 mg/kg (p<0.01) 
compared to the gentamicin group. Total protein also showed a 
significant decrease in the gentamicin-only group (p< 0.001). The 
extract increased the total protein significantly (p<0.05) at 
100mg/kg and 300 mg/kg compared to the control group. At 1000 
mg/kg of extract total protein levels increased significantly (p< 
0.01) compared to the gentamicin group (Table 4).  
 
Effect of TIE and Gentamicin on globulin and albumin levels 
Globulin levels were significantly low (p< 0.01) in the 
gentamicin-only group when compared to the control group. The 
extract at 300 and 1000 mg/kg significantly increased (p< 0.05) 










































levels were also decreased in gentamicin (p< 0.001) and p< 0.05 
(100 and 300 mg/kg of extract) as compared to the control group. 
Extract at 1000 mg/kg however significantly elevated (p< 0.05) 
albumin levels as compared to the gentamicin group (Table 5).  
 
Photomicrographs of rat liver showing the effect of TIE on 
gentamicin–induced hepatic damage 
Assessment of liver histology showed normal liver 
histology in the control group. The gentamicin group showed 
congested hepatic sinusoids and blood vessels, apoptotic cells, 
severe vacuolization and necrosis. The extract at all doses showed 
improved the liver architecture with no visible lesions similar to 
the control group (Figure 7). The observations on the 
photomicrographs correlated well with the biochemical findings.  
       
                                  (A) Control                                                    (B) Gentamicin (80 mg/kg)                             (C) 100 mg/kg TIE&gentamicin (80 mg/kg) 
 
           
(D) 300 mg/kg TIE & gentamicin (80 mg/kg)              (E) 1000 mg/kg TIE & gentamicin (80 mg/kg) 
Fig. 6: Effect of gentamicin 80 mg/kg and TIE (100, 300, 1000 mg/kg) on kidney histology. 
 
Table 3: Effect of TIE and Gentamicin on AST, ALT and GGT levels. 
Treatment group AST / U/L ALT/ U/L GGT / U/L 
Control: distilled 10 ml/kg 298.8 ± 4.9 116.2 ± 13.1 1.6 ± 0.12 
Gent 80 mg/kg 985.5 ± 270.5* 218.8 ± 29.6** 4.6 ± 0.77** 
TIE 100 mg/kg + Gent 80 mg/kg 709.0 ± 145.5 142.8 ± 15.6 3.8 ± 0.73 
TIE 300 mg/kg + Gent 80 mg/kg 447.4 ± 38.9 122.2 ± 15.9ᵗ 2.8 ± 0.46 
TIE 1000 mg/kg + Gent 80 mg/kg 361.2 ± 26.8ᵗ 126.2 ± 4.3ᵗ 2.0 ± 0.17ᵗ 
All data are expressed as mean ± S.E.M. (n=6), *p< 0.05 and **p< 0.01 as compared to control group.  ᵗp< 0.05 and ᵗᵗp< 0.01 as compared to gentamicin group 
(one way ANOVA followed by Sidak’s post hoc test).  
 
Table 4: Effect of TIE and Gentamicin on ALP, total bilirubin, and total protein levels. 
Treatment group ALP / U/L Total bilirubin/ μmol/L Total protein / g/L 
Control: distilled 10 ml/kg 176.9 ± 23.7 4.2 ± 0.49 71.0 ± 0.81 
Gent 80 mg/kg 296.7 ± 15.5** 6.3 ± 0.49** 56.3 ± 2.63*** 
TIE 100 mg/kg + Gent 80 mg/kg 228.4 ± 13.2 4.9 ± 0.16 61.6 ± 2.65* 
TIE 300 mg/kg + Gent 80 mg/kg 224.9 ± 32.2 4.6 ± 0.19ᵗ 61.2 ± 1.14* 
TIE 1000 mg/kg + Gent 80 mg/kg 189.6 ± 14.3ᵗ 4.2 ± 0.25ᵗᵗ 66.3 ± 1.34ᵗᵗ 
All data are expressed as mean ± S.E.M. (n=6), *p< 0.05, **p< 0.01 and ***p< 0.001 as compared to control group.  ᵗp< 0.05 and ᵗᵗp< 0.01 as compared to 
gentamicin group (one way ANOVA followed by Sidak’s post hoc test).  
 


































Medicinal plants play a crucial role as the first line 
treatment for various diseases especially in the West Africa sub-
region due to their low cost, easy accessibility and minimal side 
effects (Annan et al., 2012; Gopalakrishnan and Dhanapal, 2014). 
In spite of the wide use of these plants for the cure of many 
diseases, the safety or potential toxicity of many of these plants 
has not been scientifically investigated (Ansah et al., 2009).  
Among the plants used by herbalists include Terminalia 
ivorensis, which is used for ulcers, wounds, diuresis, general body 
pains, malaria, hemorrhoids and yellow fever (Burkill, 1985; 
Etukudo, 2003; Akinyemi et al., 2006; Quattara et al., 2013). It is 
also used as timber, anti-cough, anti-hyperglycemic, anti-parasitic 
anti-inflammatory and anti-arthritis as well as for skin and oral 
infections (Iwu and Anyanwu, 1982; Agbedahunsi, 2006; Johnny 
et al., 2014).  
However, very little is known about its effect on 
nephrotoxic and hepatotoxic effects induced by gentamicin. The 
present study examined the possible nephroprotective and 
hepatoprotective effects of Terminalia ivorensis ethanolic stem 
bark extract against gentamicin-induced toxicity in Sprague-
Dawley rats. Nephrotoxicity is an adverse effect of chemotherapy 































depends on their build-up in renal cortex, affinity to kidneys and 
the kinetics of drug trapping process (Noorani et al., 2010). 
Gentamicin is a commonly used aminoglycoside for the cure of 
life threatening gram-negative infections. It usually accumulates in 
the renal proximal tubules and enhances hydrogen peroxide 
generation by the mitochondria (Noorani et al., 2010). The 
hydrogen peroxide produced causes the release of iron from 
mitochondria membranes which complexes with gentamicin to 
evoke the generation of reactive oxygen species (Afeefa et al., 
2012). This antibiotic has been shown to dose-dependently induce 
nephrotoxicity when administered for more than 7-10 days 
(Noorani et al., 2010; Geevasinga et al., 2006).  
Gentamicin at 80 mg/kg body weight administered 
intraperitoneally for two consecutive weeks in rats is known to 
cause significant nephrotoxicity (Qadir et al., 2011; Chatterjee et 
al., 2012). In this study, gentamicin (80 mg/kg administered for 14 
days), induced renal dysfunction which was evidenced by 
significant increase in serum urea, creatinine and electrolytes with 
obvious histological injury. 
The elevated levels of serum markers were significantly 
reduced in extract pretreated groups (300 and 1000 mg/kg) when 
compared to the gentamicin treated groups. The reduction in the 
renal markers (creatinine and urea) and serum electrolytes 
(sodium, potassium and chloride) demonstrated that the extract 
         
                                            (A)Control                                              (B) Gentamicin (80 mg/kg)                        (C) 100 mg/kg TIE& gentamicin (80mg/kg) 
(A)  
              
(D) 300 mg/kgTIE& gentamicin (80 mg/kg)          (E) 1000 mg/kg TIE& gentamicin (80 mg/kg) 
Fig. 7: Effect of gentamicin 80 mg/kg and TIE (100, 300, 1000 mg/kg) on liver histology. 
 
Table 5: Effect of TIE and Gentamicin on globulin and albumin levels 
Treatment group Globulin / g/L Albumin / g/L 
Control: distilled 10 ml/kg 25.5 ± 0.62 44.3 ± 0.94 
Gent 80 mg/kg 19.8 ± 0.82** 37.7 ± 0.71*** 
TIE 100 mg/kg + Gent 80 mg/kg 22.6 ± 0.86 39.7 ± 0.54* 
TIE 300 mg/kg + Gent 80 mg/kg 24.5 ± 1.40ᵗ 40.3 ± 1.45* 
TIE 1000 mg/kg + Gent 80 mg/kg 24.1 ± 0.88ᵗ 41.8 ± 0.47ᵗ 
All data are expressed as mean ± S.E.M. (n=6), *p< 0.05, **p< 0.01 and ***p< 0.001 as compared to control group.  ᵗp< 0.05 as compared to gentamicin group 
(one way ANOVA followed by Sidak’s post hoc test).  
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minimized cell damage caused by gentamicin thereby improving 
renal function. In several animal models, oxidative stress has been 
strongly linked to nephrotoxicity and hepatotoxicity. During 
toxicity, there is a build-up of reactive species, which results in an 
oxidative degradation of lipids, proteins and DNA (Girotti, 1998). 
Exposure of an organism to gentamicin causes a build-up of 
oxidative stress in the system (Chatterjee et al., 2012, Gowrisri et 
al., 2012), which is evidenced by diminished levels of GSH, SOD 
and catalase as well as increase in lipid peroxidation and cellular 
damage (Gowrisri et al., 2012) 
In this study, as expected, gentamicin significantly 
decreased SOD, GSH and catalase levels and caused an increasein 
lipid peroxidation, myeloperoxidase and tissue damage. Extract 
pretreated animals showed significantly elevated superoxide 
dismutase (SOD), reduced glutathione (GSH) and catalase levels 
as compared to the gentamicin group. The formation of 
myeloperoxidase and the lipid peroxidation product (MDA) were 
also observed to be significantly reduced when compared to the 
gentamicin-only treated group. The activity shown by Terminalia 
ivorensis ethanolic stem bark extract might be due to its ability to 
induce antioxidant enzymes as observed in the present study. 
Kidney sections of the control rats showed normal 
architecture of tubules while the gentamicin group showed severe 
glomerular degeneration, vacuolization, tubular casts and necrosis. 
However, pretreatment of rats with extract at 100 mg/kg showed a 
moderate reduction of kidney features of injury. Again, 
pretreatment of rats with extract at 300 and 1000 mg/kg showed 
further decrease in renal injury similar to control group. 
Pretreatment of rats with extract therefore offered a protective 
effect against renal damage caused by gentamicin. 
Gentamicin has also been shown to induce hepatotoxicity 
secondary to nephrotoxicity and ototoxicity. It induces hepatic 
injury by promoting the generation of free radicals which attack 
and destroy hepatocytes (Noorani et al., 2010; Al-Kenanny et al., 
2012). Drug – induced hepatotoxicity is characterized by elevated 
levels of ALT, AST, ALP, GGT and bilirubin as well as 
destruction of tissue histology (Kurtovic and Riordan, 2003; 
Sivakrishnan and Kottaimuthu, 2013; Adejuwon et al., 2014).  
High levels of these enzymes are consequences of 
hepatocytes destruction and increase in cellular permeability 
(Sivakrishnan and Kottaimuthu, 2013), whereas increased amount 
of bilirubin is indicative of loss of functional efficiency of hepatic 
cells in binding, conjugating and excreting bilirubin (Saroswat et 
al., 1993; Singh et al., 2005).  
In this study, gentamicin showed significant increase in 
the levels of liver biomarkers (ALT, AST, ALP, GGT and 
bilirubin) and decrease levels of total proteins, globulin and 
albumin as well as cause severe liver destruction. However, co-
administration of extract and gentamicin significantly normalized 
the levels of these markers and restored liver structure. This 
finding correlates with previous reports by Noorani et al., (2010) 
and Al-Kenannay et al., (2012), who also showed that gentamicin 
induces hepatotoxicity evidenced by elevated levels of serum 
enzymes. Ethanolic stem bark extract of Terminalia ivorensis 
significantly reduced the damage caused by gentamicin probably 
through a protective effect against cellular destruction and 




Terminalia ivorensis has nephroprotective and 
hepatoprotective effects against gentamicin-induced toxicity by 
enhancing kidney and liver functions evidenced by reversal in the 
alteration of renal and hepatic markers of cellular damage and 
restoration of cellular structure. The mechanism of the nephro-
protection and hepatoprotection of T. ivorensisis proposed to be by 
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